Alligator Bioscience AB
STO:ATORX

Watchlist Manager
Alligator Bioscience AB Logo
Alligator Bioscience AB
STO:ATORX
Watchlist
Price: 4.921 SEK 17.12% Market Closed
Market Cap: 152m SEK

Relative Value

The Relative Value of one ATORX stock under the Base Case scenario is 14.822 SEK. Compared to the current market price of 4.921 SEK, Alligator Bioscience AB is Undervalued by 67%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ATORX Relative Value
Base Case
14.822 SEK
Undervaluation 67%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
96
vs Industry
75
Median 3Y
49.9
Median 5Y
113.4
Industry
7.2
Forward
1.3
vs History
vs Industry
Median 3Y
-9.5
Median 5Y
-14.7
Industry
23.2
Forward
-59.7
vs History
vs Industry
Median 3Y
-10.6
Median 5Y
-16.6
Industry
19.3
vs History
vs Industry
Median 3Y
-13.5
Median 5Y
-16.8
Industry
22.5
vs History
vs Industry
0
Median 3Y
10.2
Median 5Y
16.1
Industry
2.7
vs History
96
vs Industry
68
Median 3Y
48.9
Median 5Y
106.9
Industry
7.5
Forward
1.3
vs History
vs Industry
Median 3Y
0
Median 5Y
0
Industry
9.4
vs History
vs Industry
Median 3Y
-10.9
Median 5Y
-14.8
Industry
4.6
Forward
-2.4
vs History
vs Industry
Median 3Y
-10.4
Median 5Y
-13.9
Industry
4.5
Forward
-2.2
vs History
vs Industry
Median 3Y
-10.4
Median 5Y
-15.2
Industry
4.9
vs History
vs Industry
Median 3Y
-10.3
Median 5Y
-15.2
Industry
3.7
vs History
96
vs Industry
40
Median 3Y
40.3
Median 5Y
57.6
Industry
4.9

Multiples Across Competitors

ATORX Competitors Multiples
Alligator Bioscience AB Competitors

Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Alligator Bioscience AB
STO:ATORX
152m SEK 3 -0.8 -0.9 -0.7
FR
Pharnext SCA
OTC:PNEXF
6T USD 34 536 021.3 -164 144.6 -199 323.9 -197 049.4
US
Abbvie Inc
NYSE:ABBV
327.6B USD 5.7 78.8 15.1 22.3
US
Amgen Inc
NASDAQ:AMGN
156B USD 4.6 26.3 14.2 23.4
US
Gilead Sciences Inc
NASDAQ:GILD
134.5B USD 4.7 22.5 9.8 13.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
113.6B USD 10.2 -114.9 24.4 25.5
US
Epizyme Inc
F:EPE
94.1B EUR 2 039.9 -520.5 -566.8 -551.7
AU
CSL Ltd
ASX:CSL
116B AUD 4.9 27.3 16.9 21.1
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
55.1B USD 3.9 12.2 10.8 12.2
US
Seagen Inc
F:SGT
39.3B EUR 19.6 -60.3 -64.9 -58.6
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
40.2B USD 17.1 -149.2 -668 -334.8
P/E Multiple
Earnings Growth PEG
SE
Alligator Bioscience AB
STO:ATORX
Average P/E: 33.4
Negative Multiple: -0.8
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -164 144.6 N/A N/A
US
Abbvie Inc
NYSE:ABBV
78.8
88%
0.9
US
Amgen Inc
NASDAQ:AMGN
26.3
45%
0.6
US
Gilead Sciences Inc
NASDAQ:GILD
22.5
188%
0.1
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Negative Multiple: -114.9 N/A N/A
US
E
Epizyme Inc
F:EPE
Negative Multiple: -520.5 N/A N/A
AU
CSL Ltd
ASX:CSL
27.3
16%
1.7
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.2
7%
1.7
US
S
Seagen Inc
F:SGT
Negative Multiple: -60.3 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -149.2 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
SE
Alligator Bioscience AB
STO:ATORX
Average EV/EBITDA: 15.2
Negative Multiple: -0.9
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -199 323.9 N/A N/A
US
Abbvie Inc
NYSE:ABBV
15.1
13%
1.2
US
Amgen Inc
NASDAQ:AMGN
14.2
17%
0.8
US
Gilead Sciences Inc
NASDAQ:GILD
9.8
6%
1.6
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
24.4
17%
1.4
US
E
Epizyme Inc
F:EPE
Negative Multiple: -566.8 N/A N/A
AU
CSL Ltd
ASX:CSL
16.9
11%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
10.8
11%
1
US
S
Seagen Inc
F:SGT
Negative Multiple: -64.9 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -668 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
SE
Alligator Bioscience AB
STO:ATORX
Average EV/EBIT: 19.7
Negative Multiple: -0.7
N/A N/A
FR
Pharnext SCA
OTC:PNEXF
Negative Multiple: -197 049.4 N/A N/A
US
Abbvie Inc
NYSE:ABBV
22.3
29%
0.8
US
Amgen Inc
NASDAQ:AMGN
23.4
32%
0.7
US
Gilead Sciences Inc
NASDAQ:GILD
13.6
11%
1.2
US
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
25.5
17%
1.5
US
E
Epizyme Inc
F:EPE
Negative Multiple: -551.7 N/A N/A
AU
CSL Ltd
ASX:CSL
21.1
14%
1.5
US
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
12.2
11%
1.1
US
S
Seagen Inc
F:SGT
Negative Multiple: -58.6 N/A N/A
US
Alnylam Pharmaceuticals Inc
NASDAQ:ALNY
Negative Multiple: -334.8 N/A N/A